Our Peptide and Oligonucleotide Editorial Focus eBook offers a curated collection of forward-thinking research, expert commentary, and clinical developments that are reshaping the way targeted therapies are designed, delivered, and manufactured.
Download the full eBook
From next-gen peptide engineering to the expanding potential of RNA-based treatments, the eBook explores the molecular innovations driving a new era in precision medicine.
Inside, you'll find in-depth coverage of key advances in intracellular delivery, regenerative bioactive peptides, and emerging therapeutic pathways, all of which are propelling progress in areas such as metabolic disease, bone health, and complex biologics.
This eBook also takes a closer look at how the evolving biopharma landscape is responding to rising demand for molecules such as GLP-1, spotlighting new production strategies and analytical approaches that can help manufacturers meet both clinical needs and market expectations.
Analytical rigor is a recurring theme throughout. High-field NMR spectroscopy stands out as a critical tool for structural analysis, quality control, and impurity profiling across both peptides and oligonucleotides.
With practical how-to guides, real-world case studies, and application-driven insights, this Editorial Focus is a valuable resource for scientists, researchers, and biopharma professionals working at the forefront of therapeutic innovation.
Download your free copy to stay informed on the science and strategy shaping the next generation of advanced medicines.
Download the full eBook
About Bruker BioSpin Group
Welcome to Bruker BioSpin and the world's most comprehensive range of NMR and EPR spectroscopy and preclinical imaging research tools. The Bruker BioSpin Group of companies develops, manufactures, and supplies technology to research establishments, commercial enterprises, and multi-national corporations across countless industries and fields of expertise.
Bruker BioSpin is continuing to revolutionize the design, manufacture, and distribution of life science, preclinical, process control, and analytical research tools based on magnetic resonance and multimodal imaging technologies. Bruker BioSpin is the global technology and market leader in magnetic resonance technologies (NMR, EPR), offering the largest portfolio of imaging modalities for preclinical and industrial research under a single brand.
Sponsored Content Policy: News-Medical.net publishes articles and related content that may be derived from sources where we have existing commercial relationships, provided such content adds value to the core editorial ethos of News-Medical.net, which is to educate and inform site visitors interested in medical research, science, medical devices, and treatments.